BPC-157 Legal Status in the United States: Federal and State Rules

BPC-157 holds a curious legal position in the United States. It does not fall under the category of a controlled substance, dietary supplement, or licensed medication. The law does not actually disallow ownership of the drug, but marketing it as a medicinal product is illegal without proper FDA sanction. There are different regulations depending on whether you are purchasing, selling, registering, manufacturing, or participating in sports.

Federal Legal Framework for BPC-157

Not a Controlled Substance

BPC-157 is not on the Drug Enforcement Administration's list of controlled substances. It is not scheduled under the Controlled Substances Act (21 U.S.C. § 812). This means possessing BPC-157 is not a federal crime in the way possessing heroin, cocaine or anabolic steroids would be. The DEA has not proposed scheduling BPC-157 as of October 2026.

Not an Approved Drug

BPC-157 has never received FDA approval as a drug for any indication. No company has filed a New Drug Application. Under the FD&C Act (21 U.S.C. § 355), introducing an unapproved new drug into interstate commerce is illegal. This prohibition applies to sellers and distributors, not to individual buyers. Our FDA page covers the agency's actions in detail.

Not a Dietary Supplement

BPC-157 does not qualify as a dietary supplement under DSHEA. It is a synthetic peptide with no history of use as a food ingredient before the 1994 cutoff date. The FDA has not received a New Dietary Ingredient Notification for BPC-157. Vendors who sell it as a supplement are violating federal law.

Compounding Pharmacy Rules

503A Pharmacies

Section 503A of the FD&C Act allows licensed pharmacies to compound drugs for individual patients with valid prescriptions. However, the substance being compounded must appear on the FDA's positive list of bulk drug substances, or be a component of an FDA-approved drug. BPC-157 appears on neither list. Its Category 2 classification (significant safety concerns) means it is not eligible for addition to the positive list under current FDA policy.

503B Outsourcing Facilities

According to Section 503B, outsourcing facilities that are registered can make batches of medicines without the need of obtaining prescriptions. These facilities must follow the cGMP requirements and are subject to FDA inspections. Like the pharmacies covered under Section 503A, outsourcing facilities can only use substances which are listed. BPC-157 cannot be used as one of the components. Our compounding rules page has more details on this.

Sports Ban

WADA and USADA

BPC-157 is on the WADA Prohibited List under S0 (Non-Approved Substances) and has been explicitly named since 2022. The US Anti-Doping Agency (USADA) enforces this list for American Olympic and Paralympic athletes. A positive test for BPC-157 carries a standard four-year ban for the first violation. Our WADA page covers testing, detection and sanctions.

NCAA

The NCAA has its list of compounds that may pose risks of performance enhancement. Peptides that may have the ability to enhance performance could appear on its list of banned substances. Our NCAA page discusses the specific regulations that apply to student athletes.

State-Level Regulation

State Pharmacy Boards

Pharmacy boards in different states oversee compounding activities within their localities of jurisdiction. Some states have stricter rules than federal law regarding the compounding of substances. A pharmacy that legally compounds medications according to the federal law 503A must also follow the regulations of the state pharmacy board. States can restrict or prohibit the compounding of certain substances on their own.

State Consumer Protection

Policing actions can be instituted by state attorney generals as per the consumer protection law against any business that offers deceptive claims about its products. These actions can be taken independently of the enforcement measures taken by the FDA and may involve other aspects of the business other than the aspect of advertising.

State Telehealth Laws

Clinics that offer BPC-157 consultations through telehealth must be in compliance with federal as well as state laws governing telehealth operations. Each state has its own set of rules about patient-physician relations, what medications one can prescribe (both controlled and non-controlled drugs), and how telemedicine may be used. So while telehealth services may be legal in one state, corresponding activities may violate telehealth legislation of another state.

Buyer Legal Position

Individual Possession

As of October 2026, there are no federal laws that specifically criminalize the possession of BPC-157 by an individual. It is not a controlled substance. Individual buyers purchasing small quantities from research chemical vendors have not been the target of FDA enforcement actions. This does not mean possession is legal in all circumstances. It means the enforcement focus has been on sellers.

Import Risk

The process of ordering BPC-157 internationally can pose a different risk for those ordering it. The FDA may hold shipments of unapproved drugs while at the border. Customs and Border Protection may confiscate shipments containing peptides without a valid drug label. Learn what occurs at the border in our customs and import page article.